The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 23, 2024
Filed:
May. 13, 2021
Applicant:
Cybin Uk Ltd, London, GB;
Inventors:
Peter Rands, London, GB;
Tiffanie Benway, London, GB;
Zelah Joel, London, GB;
Marie Layzell, London, GB;
Ellen James, London, GB;
Assignee:
CYBIN UK LTD, London, GB;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4045 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 9/50 (2006.01); C07B 59/00 (2006.01); C07D 209/16 (2006.01);
U.S. Cl.
CPC ...
A61K 9/485 (2013.01); A61K 9/0053 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 9/5057 (2013.01); A61K 31/4045 (2013.01); C07B 59/002 (2013.01); C07D 209/16 (2013.01); C07B 2200/05 (2013.01);
Abstract
The present invention relates to a solid dosage form comprising two or more compounds selected from N,N-dimethyltryptamine and its deuterated analogues and pharmaceutically acceptable salts thereof, and methods of treatment (e.g., of a psychiatric disorder or a neurological disorder) comprising administering the solid dosage form to a patient in need thereof.